UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine
ISSN 2079-0325(p)
DOI 10.36927/2079-0325

PSYCHOLOGICAL-PSYCHIATRIC CONSEQUENCES OF ALOPECIA: A STUDY OF PATIENTS’ COGNITIVE FUNCTIONING

Type of Article

In the Section

Abstract

The purpose of the work is to study the features of cognitive functioning of patients with different types of alopecia, to understand the targets of medical and psychological rehabilitation of this contingent.

The study included 153 women diagnosed with diffuse alopecia. Depending on the state of the mental sphere and the genesis of alopecia, 6 subgroups were formed: patients with metabolic alopecia without signs of maladaptation-G1-1 (30 patients), with metabolic alopecia with individual signs of maladaptation (risk group)-G1-2 (9), with metabolic alopecia and the presence of adaptation disorders-G1-3 (6 patients), with mixed alopecia without signs of maladaptation-G2-1 (15 patients), with mixed alopecia with separate signs of maladaptation (risk group)-G2-2 (64) and with mixed adaptation and adaptation disorders-G2-3 (29 patients).

Affection of patients with alopecia by disorders of cognitive functioning is significant, and more significant in patients with mixed alopecia.

In both metabolic and mixed alopecia patients, cognitive impairment was more often detected in patients with adaptation disorders, and less often in patients at risk and without signs of PD. At the same time, the patterns of cognitive impairment in alopecia are complex, nonlinear, and require further study

Prospects for further research are related to the search for connections between cognitive impairment in different forms of alopecia with various clinical and psychosocial factors, as well as the development of personalized measures to correct cognitive impairment in the structure of medical and psychological rehabilitation of patients with alopecia.

Pages

References

  1. Piraccini BM, Alessandrini A. Androgenetic alopecia. G Ital Dermatol Venereol. 2014 Feb;149(1):15-24. PMID: 24566563.
  2. Psychodermatology. Medical and psychological aspects of the effect of psychosocial stress in clinical and aesthetic dermatological practice : a collective monograph edited by Prof. M. V. Markova, MD I. R. Mukharovska. Kharkiv : Printing house "Madrid", 2019. 277 p. / [Psychodermatology. Medical and psychological aspects of the effects of psychosocial stress in clinical and aesthetic dermatological practice]: a collective monograph edited by Prof. M. V. Markova, Dr. Med. Sci. I. R. Mukharovska. Kharkiv: Madrid Printing House, 2019. 277 p. (In Ukrainian).
  3. Dhami L. Psychology of Hair Loss Patients and Importance of Counseling. Indian J Plast Surg. 2021 Dec 31;54(4):411-415. doi: https://doi.org/10.1055/s-0041-1741037.
  4. Aldhouse NVJ, Kitchen H, Knight S, Macey J, Nunes FP, Dutronc Y, et al. “‘You lose your hair, what’s the big deal?’ I was so embarrassed, I was so self-conscious, I was so depressed:” a qualitative interview study to understand the psychosocial burden of alopecia areata. J Patient Rep Outcomes. 2020 Sep 11;4(1):76. doi: https://doi.org/10.1186/s41687-020-00240-7.
  5. Aukerman E.L., Jafferany M. The psychological consequences of  androgenetic alopecia: A  systematic review  // J Cosmet Dermatol. 2023. 22(1). 89-95. doi: https://doi.org/10.1111/jocd.14983.
  6. Titeca G, Goudetsidis L, Francq B, Sampogna F, Gieler U, Tomas-Aragones L, et al. ‘The psychosocial burden of alopecia areata and androgenetica’: a cross-sectional multicentre study among dermatological out-patients in 13 European countries. J Eur Acad Dermatol Venereol. 2020 Feb;34(2):406-411. doi: https://doi.org/10.1111/jdv.15927. Erratum in: J Eur Acad Dermatol Venereol. 2020 May;34(5):1119. doi: https://doi.org/10.1111/jdv.16298.
  7. Huang C., Fu Y., Chi C. Health‐related quality of life, depression, and self‐esteem in patients with androgenetic alopecia: a systematic review and meta‐analysis. JAMA Dermatol. 2021 Aug 1;157(8):963-970. doi: https://doi.org/10.1001/jamadermatol.2021.2196.
  8. Zac RI, da Costa A. Patient satisfaction and quality of life among adult women with androgenetic alopecia using 5 % topical minoxidil. J Clin Aesthet Dermatol. 2021 May;14(5):26- 30. PMID: 34188746; PMCID: PMC8211325.
  9. Mesinkovska N, King B, Mirmirani P, Ko J, Cassella J. Burden of illness in alopecia areata: a cross-sectional online survey study. J Investig Dermatol Symp Proc. 2020 Nov;20(1):S62- S68. doi: https://doi.org/10.1016/j.jisp.2020.05.007.
  10. Marahatta S, Agrawal S, Adhikari BR. Psychological Impact of Alopecia Areata. Dermatol Res Pract. 2020Dec 24;2020:8879343. doi: https://doi.org/10.1155/2020/8879343.
  11. Torales J, Castaldelli-Maia JM, Ventriglio A, Almirón-Santacruz J, Barrios I, O’Higgins M, et al. Alopecia areata: A psychodermatological perspective. J Cosmet Dermatol. 2022 Jun;21(6):2318-2323. doi: https://doi.org/10.1111/jocd.14416.
  12. Toussi A, Barton VR, Le ST, Agbai ON, Kiuru M. Psychosocial and psychiatric comorbidities and health-related quality of life in alopecia areata: a systematic review. J Am Acad Dermatol. 2021 Jul;85(1):162-175. doi: https://doi.org/10.1016/j.jaad.2020.06.047.
  13. Tzur Bitan D, Berzin D, Kridin K, Cohen A. The  association between alopecia areata and anxiety, depression, schizophrenia, and bipolar disorder: a population-based study. Arch Dermatol Res. 2022 Jul;314(5):463-468. doi: https://doi.org/10.1007/s00403-021-02247-6.
  14. Macbeth AE, Holmes S, Harries M. Chiu WS, et al. The associated burden of mental health conditions in alopecia areata: a population-based study in UK primary care. British Journal of Dermatology. 2022;187:73–81. doi: https://doi.org/10.1111/bjd.21055.
  15. Senna M, Ko J, Glashofer M, et al. Predictors of quality of life in patients with alopecia areata. J Invest Dermatol. 2022. Oct;142(10):2646-2650.e3. doi: https://doi.org/10.1016/j.jid.2022.02.019.
  16. Gelhorn HL, Cutts K, Edson-Heredia E, et  al. The  relationship between patient-reported severity of  hair loss and health-related quality of  life and treatment patterns among patients with alopecia areata. Dermatol Ther. 2022 Apr;12(4):989-997. doi: https://doi.org/10.1007/s13555-022-00702-4.
  17. Mesinkovska N, Craiglow B, Ball SG, Morrow P, Smith SG, Pierce E, Shapiro J. The Invisible Impact of a Visible Disease: Psychosocial Impact of Alopecia Areata. Dermatol Ther (Heidelb). 2023 Jul;13(7):1503-1515. doi: https://doi.org/10.1007/s13555-023-00941-z.
  18. King BA, Senna MM, Ohyama M, Tosti A, Sinclair RD, Ball  S, et  al. Defining severity in  alopecia areata: current perspectives and a  multidimensional framework. Dermatol Ther (Heidelb). 2022 Apr;12(4):825-834. doi: https://doi.org/10.1007/s13555-022-00711-3.
  19. King BA, Mesinkovska NA, Craiglow B, et al. Development of the alopecia areata scale for clinical use: results of an academic-industry collaborative effort. J Am Acad Dermatol. 2022 Feb;86(2):359–364. doi: https://doi.org/10.1016/j.jaad.2021.08.043.